Literature DB >> 11437931

Early development of vaginal shortening during radiation therapy for endometrial or cervical cancer.

A Katz1, E Njuguna, E Rakowsky, A Sulkes, J Sulkes, E Fenig.   

Abstract

Vaginal necrosis can occur following radiation therapy for gynecological malignancies. The distal vaginal mucosa has a poorer radiation tolerance than the mucosa in the upper region. We examined the extent of vaginal shortening in patients treated by intravaginal brachytherapy with or without pelvic irradiation. Maximal extension of the vaginal cylinder above the pubis was measured for each insertion. We found that the difference in mean values between insertions (2.3 vs. 1.7 cm) was highly statistically significant (P < 0.0001). Our study shows that vaginal shortening can occur during the course of intracavity and external irradiation. These alterations in vaginal anatomy can have important consequences on doses received by the distal vaginal mucosa.

Entities:  

Mesh:

Year:  2001        PMID: 11437931     DOI: 10.1046/j.1525-1438.2001.01019.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  11 in total

1.  Dosimetric Predictors of Radiation-Induced Vaginal Stenosis After Pelvic Radiation Therapy for Rectal and Anal Cancer.

Authors:  Christina H Son; Ethel Law; Jung Hun Oh; Aditya P Apte; T Jonathan Yang; Elyn Riedel; Abraham J Wu; Joseph O Deasy; Karyn A Goodman
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-04-28       Impact factor: 7.038

2.  Sexual function after intracavitary vaginal brachytherapy for early-stage endometrial carcinoma.

Authors:  Allison M Quick; Leigh G Seamon; Mahmoud Abdel-Rasoul; Ritu Salani; Douglas Martin
Journal:  Int J Gynecol Cancer       Date:  2012-05       Impact factor: 3.437

3.  Prospective study of vaginal dilator use adherence and efficacy following radiotherapy.

Authors:  Ethel Law; Joanne F Kelvin; Bridgette Thom; Elyn Riedel; Ashlyn Tom; Jeanne Carter; Kaled M Alektiar; Karyn A Goodman
Journal:  Radiother Oncol       Date:  2015-07-08       Impact factor: 6.280

4.  Tolerance of the vaginal vault to high-dose rate brachytherapy and concomitant chemo-pelvic irradiation: Long-term perspective.

Authors:  Orit Kaidar-Person; Roxolyana Abdah-Bortnyak; Amnon Amit; Alexander Nevelsky; Alison Berniger; Raquel Bar-Deroma; Rahamim Ben-Yosef; Abraham Kuten
Journal:  Rep Pract Oncol Radiother       Date:  2013-10-16

Review 5.  Maintaining sexual health throughout gynecologic cancer survivorship: A comprehensive review and clinical guide.

Authors:  Laura B Huffman; Ellen M Hartenbach; Jeanne Carter; Joanne K Rash; David M Kushner
Journal:  Gynecol Oncol       Date:  2015-11-07       Impact factor: 5.482

6.  An examination of the sexual functions of patients who underwent a gynecologic cancer operation and received brachytherapy.

Authors:  Ozlem Guner; Sureyya Gumussoy; Nigar Celik; Aynur Saruhan; Oya Kavlak
Journal:  Pak J Med Sci       Date:  2018 Jan-Feb       Impact factor: 1.088

Review 7.  Managing female sexual dysfunction.

Authors:  Sarah S Arthur; Caroline S Dorfman; Lisa A Massa; Rebecca A Shelby
Journal:  Urol Oncol       Date:  2021-07-08       Impact factor: 2.954

Review 8.  Emotional and sexual concerns in women undergoing pelvic surgery and associated treatment for gynecologic cancer.

Authors:  Cara Stabile; Abigail Gunn; Yukio Sonoda; Jeanne Carter
Journal:  Transl Androl Urol       Date:  2015-04

Review 9.  Vaginal toxicity after high-dose-rate endovaginal brachytherapy: 20 years of results.

Authors:  Durim Delishaj; Amelia Barcellini; Romerai D'Amico; Stefano Ursino; Francesco Pasqualetti; Ilaria Costanza Fumagalli; Carlo Pietro Soatti
Journal:  J Contemp Brachytherapy       Date:  2018-12-28

10.  Intrafractional vaginal dilation in anal cancer patients undergoing pelvic radiotherapy (DILANA) - a prospective, randomized, 2-armed phase-II-trial.

Authors:  Nathalie Arians; Matthias Häfner; Johannes Krisam; Kristin Lang; Antje Wark; Stefan A Koerber; Adriane Hommertgen; Jürgen Debus
Journal:  BMC Cancer       Date:  2020-01-21       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.